首页> Journal of Alzheimer's disease: JAD> A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

导出原文传递

翻译打印收藏纠错

第一作者： Blivet, Guillaume

作者： Blivet, Guillaume ^[1] ; Relano-Gines, Aroa ^[2] ; Wachtel, Melanie ^[3] ; Touchon, Jacques

作者单位： REGEnLIFE ^[1] ICTA PM ^[2] Univ Montpellier ^[3]

关键词 Alzheimer's disease brain-gut axis cognition dementia memory neurodegenerative diseases optics and photonics photobiomodulation MAGNETIC-FIELD STIMULATION ALZHEIMERS-DISEASE DEMENTIA MECHANISMS BODY

发布时间 2023-02-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Alzheimer's disease

2022年90卷2期

811-822页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Journal of Alzheimer's disease

2022年90卷2期

811-822页

检索历史清除

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

Journal of Alzheimer's disease

相似文献

同项目论文

Journal of Alzheimer's disease

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

Journal of Alzheimer's disease

相似文献

同项目论文

Journal of Alzheimer's disease

相关期刊

检索历史清除